Dx & Vx Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yong Gu Lee

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.5yrs
CEO ownership0.06%
Management average tenure1.2yrs
Board average tenureno data

Recent management updates

Recent updates

Positive Sentiment Still Eludes Dx & Vx Co., Ltd. (KOSDAQ:180400) Following 27% Share Price Slump

Oct 21
Positive Sentiment Still Eludes Dx & Vx Co., Ltd. (KOSDAQ:180400) Following 27% Share Price Slump

Market Cool On Dx & Vx Co., Ltd.'s (KOSDAQ:180400) Revenues Pushing Shares 39% Lower

Jul 15
Market Cool On Dx & Vx Co., Ltd.'s (KOSDAQ:180400) Revenues Pushing Shares 39% Lower

Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 37%

May 31
Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 37%

Investors Give Dx & Vx Co., Ltd. (KOSDAQ:180400) Shares A 25% Hiding

Mar 18
Investors Give Dx & Vx Co., Ltd. (KOSDAQ:180400) Shares A 25% Hiding

Dx & Vx (KOSDAQ:180400) Is Carrying A Fair Bit Of Debt

Mar 08
Dx & Vx (KOSDAQ:180400) Is Carrying A Fair Bit Of Debt

CEO

Yong Gu Lee

1.5yrs

Tenure

Mr. Yong Gu Lee is Chief Executive Officer of Dx & Vx Co., Ltd. from May 2023. He graduated from Hanyang University.He previously served as the leader of sales and marketing strategy teams at Hanmi Pharm,...


Leadership Team

NamePositionTenureCompensationOwnership
Yong Gu Lee
Chief Executive Officer1.5yrsno data0.065%
₩ 56.5m
Kyu-chan Kwon
President1.5yrsno data0.054%
₩ 47.3m
Sungjun Han
Chief Technology Officerless than a yearno datano data
Sang-Jin Park
Head of R&D and Directorno datano data0%
₩ 0
Kyu-hang Lee
Head of New Drug Developmentless than a yearno datano data

1.2yrs

Average Tenure

Experienced Management: A180400's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.